Chroma Therapeutics

Small molecule drugs based on chromatin biology and cell accumulation for targeted cancer and inflammation treatments.

placeAbingdon, England, United Kingdom calendar_todayFounded 2000 groups51 employees language chromatherapeutics.com

Registered entities

Innovation

88 patent families (24 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 1,522 times.

YearFilings
201223
201313
201415
20157
20167
20173
20184
20191
20202
20212

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital222%
Private equity333%
Bank & private debt222%
Other / undisclosed222%
Coming soon